FOXA1 and breast carcinoma: It is worthy to note that also the pioneer factor FoxA1 recruits ERα to H3K4me2-enriched regulatory elements in breast cancer cells [56], but only PBX1 expression correlated with metastasis formation and development of resistance to endocrine therapies in patients with ERα positive breast cancer [55].